The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Not saying they don't need biopsies,but if they hadn't got any at the end of this phase i wouldn't be too concerned,especially if they said the tumours had shrank,surely they would tell us that,and we now know it's pretty safe,obviously biopsy data would be the icing on the cake
TallPaulNY, i don't know avacta may just be part of the solution, i think Al said early on that it would take many companies to meet the demand so hopefully the gov are onto this or it will be another epic fail.I would imagine a lot going on now in the background to sort this issue and we will find out in due course.
I appreciate margins could be lower with the gov and so it would be nice to have sales in EU and ROW,but i would take lower margins to get us back to a normal,i'd like affidx to be used here as we know at the moment it seems to be the best test so why use an inferior one here,i'd want the best one used here too
Gov may get out of this innova mess by saying that it doesn't detect the latest delta variant and therefore we will now be moving to affidx which has been shown to detect the delta variant for daily testing and sweeping innova under the carpet.
They'll have to champion the tests surely,the only way to turn this around is to tell everyone that they have a test that is 100% effective for the infectious ,that would do it for me i know that.
https://mobile.twitter.com/NathanLeeTV/status/1371493279418744841/photo/3
Lets hope AS gets to christen it